Genpact FY2025 revenue rises 6.6% to $5.08 billion; diluted EPS up 9.8% to $3.13
Genpact reported fourth-quarter and full-year 2025 results on February 5, 2026, with full-year net revenues of $5.080 billion, up 6.6%, and diluted EPS of $3.13, up 9.8%. The company also guided to full-year 2026 net revenue growth of at least 7% and adjusted diluted EPS growth of about 10%, and raised its quarterly dividend 10% to $0.1875 per share.
Key points
- Full-year 2025 net income was $552 million, up 7.6%, and adjusted diluted EPS was $3.65, up 11.3%.
- Fourth-quarter 2025 net revenues were $1.319 billion, up 5.6%, and diluted EPS was $0.82, up 3.8%.
- 2026 outlook: net revenue growth of at least 7% as reported; Q1 2026 adjusted diluted EPS guided to $0.92 to $0.93.
- Quarterly dividend increased 10% to $0.1875, payable March 31, 2026 to holders of record on March 16, 2026.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 12:57 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 05, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.